Pictet Asset Management (Switzerland)’s Agilon Health AGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
$587K Buy
1,354
+398
+42% +$224K ﹤0.01% 1165
2023
Q1
$568K Buy
956
+28
+3% +$15.7K ﹤0.01% 1182
2022
Q4
$374K Buy
928
+372
+67% +$174K ﹤0.01% 1374
2022
Q3
$326K Buy
556
+109
+24% +$65.3K ﹤0.01% 1209
2022
Q2
$244K Buy
+447
New +$226K ﹤0.01% 1360

Other funds holding AGL

Pictet Asset Management (Switzerland)'s AGL Position: Q2 2023 in Review

Pictet Asset Management (Switzerland) increased its Agilon Health (AGL) stake by 42% in Q2 2023, buying an estimated $224K and bringing the position to 1,354 shares worth $587K. The position accounts for ﹤0.01% of the portfolio, ranked #1165.

Pictet Asset Management (Switzerland) first reported a position in AGL in Q2 2022 and has held it in 5 quarters since. 185 funds tracked by Wall St. Rank hold AGL as of Q2 2023.

  • Pictet Asset Management (Switzerland) held 1,354 shares of Agilon Health worth $587K as of Q2 2023.
  • Pictet Asset Management (Switzerland) bought 398 Agilon Health shares in Q2 2023, an estimated $224K.
  • Agilon Health made up ﹤0.01% of Pictet Asset Management (Switzerland)'s portfolio in Q2 2023, its #1165 holding.
  • Pictet Asset Management (Switzerland) first reported a position in Agilon Health in Q2 2022 and has held it in 5 quarters since.
  • 185 funds tracked by Wall St. Rank held Agilon Health as of Q2 2023.

Based on Pictet Asset Management (Switzerland)'s 13F filing for Q2 2023, filed 10 Aug 2023.